Editorial Comment on 'Limited success with Clostridium Collagenase Histolyticum following FDA approval for the treatment of Peyronie's disease'

被引：1

作者：

Tal, Raanan ^{[1
]}

机构：

[1] Rambam Hlth Care Campus, Nuerourol Unit, Haifa, Israel

来源：

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH | 2019年 / 31卷 / 01期

关键词：

INJECTION; SAFETY;

D O I：

10.1038/s41443-018-0086-7

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：54 / 55

页数：2

共 50 条

[1] Editorial Comment on ‘Limited success with Clostridium Collagenase Histolyticum following FDA approval for the treatment of Peyronie’s disease’
Raanan Tal
International Journal of Impotence Research, 2019, 31 : 54 - 55
[2] Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie’s disease
Peter N. Tsambarlis
Raymond Yong
Laurence A. Levine
International Journal of Impotence Research, 2019, 31 : 15 - 19
[3] Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease
Tsambarlis, Peter N.
Yong, Raymond
Levine, Laurence A.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2019, 31 (01) : 15 - 19
[4] Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease
Masterson, Thomas
Patel, Premal
Ramasamy, Ranjith
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2020, 32 (02) : 251 - 252
[5] Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie’s disease
Thomas Masterson
Premal Patel
Ranjith Ramasamy
International Journal of Impotence Research, 2020, 32 : 251 - 252
[6] Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease
Tsambarlis, Peter
Levine, Laurence A.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2020, 32 (02) : 257 - 258
[7] Re: Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie’s disease
Peter Tsambarlis
Laurence A. Levine
International Journal of Impotence Research, 2020, 32 : 257 - 258
[8] Clostridium histolyticum collagenase - is this a revolutionary medical treatment for Peyronie's disease? Editorial comment
不详
BJU INTERNATIONAL, 2016, 118 (02) : 189 - 189
[9] Re: Surgical Correction of Persistent Peyronie's Disease following Collagenase Clostridium histolyticum Treatment Editorial Comment
Morey, Allen F.
JOURNAL OF UROLOGY, 2015, 194 (03): : 761 - 761
[10] PLAQUE CALCIFICATION DECREASES THE SUCCESS OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM TREATMENT FOR PEYRONIE'S DISEASE
Wymer, K.
Ziegelmann, M.
Trost, L.
JOURNAL OF SEXUAL MEDICINE, 2018, 15 (02): : S26 - S26

← 1 2 3 4 5 →